Micheal Lilly

Trials

Studies that name Micheal Lilly as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:04 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT02939807 · A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

  Medical University of South Carolina · withdrawn · Carcinoma, Hepatocellular · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression
  P01CA203628 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Carolyn D Britten · fiscal years 2016 to 2021
  Named on NCT02939807